Evidence map›Paper›PMID 29407362›Full record

ArticleContraception2018

Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS.

Steven W Blue, Andrea J Winchell, Amy V Kaucher, Rachel A Lieberman, Christopher T Gilles, Maria N Pyra, Renee Heffron, Xuanlin Hou, Robert W Coombs, Kavita Nanda and 6 more

Abstract read
In one paragraph

Article in Contraception, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Steven W BlueEndocrine Technologies Support Core, Oregon National Primate Research Center, Beaverton, OR.
Andrea J WinchellEndocrine Technologies Support Core, Oregon National Primate Research Center, Beaverton, OR.
Amy V KaucherEndocrine Technologies Support Core, Oregon National Primate Research Center, Beaverton, OR.
Rachel A LiebermanShimadzu Scientific Instruments, Columbia, MD.
Christopher T GillesShimadzu Scientific Instruments, Columbia, MD.
Maria N PyraDepartment of Epidemiology, University of Washington, Seattle, WA.
Renee HeffronDepartment of Epidemiology, University of Washington, Seattle, WA; Department of Global Health, University of Washington, Seattle, WA.
Xuanlin HouDepartment of Global Health, University of Washington, Seattle, WA.
Robert W CoombsDepartment of Medicine, University of Washington, Seattle, WA.
Kavita NandaFHI 360, Durham, NC.
Nicole L DavisDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Athena P KourtisDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Joshua T HerbeckDepartment of Global Health, University of Washington, Seattle, WA.
Jared M BaetenDepartment of Epidemiology, University of Washington, Seattle, WA; Department of Global Health, University of Washington, Seattle, WA; Department of Medicine, University of Washington, Seattle, WA.
Jairam R LingappaDepartment of Global Health, University of Washington, Seattle, WA; Department of Medicine, University of Washington, Seattle, WA; Department of Pediatrics, University of Washington, Seattle, WA.
David W EriksonEndocrine Technologies Support Core, Oregon National Primate Research Center, Beaverton, OR. Electronic address: erikson@ohsu.edu.
University of Washington · USOregon National Primate Research Center · USCenters for Disease Control and Prevention · USFamily Health International 360 · USNational Center for Chronic Disease Prevention and Health Promotion · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
YR 50 PROJ- ROBERTS PRIMATE ISLETP51RR000163 · NCRR · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI FRUH, KLAUS J · 1985 to 2011
$140.8M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Quantifying the impact of genital mucosal inflammation on HIV-1 acquisition riskR01AI111738 · NIAID · UNIVERSITY OF WASHINGTON · PI LINGAPPA, JAIRAM RAO · 2014 to 2017
$2.3M
ACL HHS U48DP005013NCRR NIH HHS P51 RR000163NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI111738NIH HHS P51 OD011092
6 · The paper itself

Abstract

objectiveThe objective was to develop a method to simultaneously quantify five commonly used hormonal contraceptives (HCs) and two endogenous sex steroids by liquid chromatography-tandem triple quadrupole mass spectrometry (LC-MS/MS) and apply this method to human serum samples. STUDY

designWe developed a method to simultaneously analyze ethinyl estradiol (EE2), etonogestrel (ENG), levonorgestrel (LNG), medroxyprogesterone acetate (MPA) and norethisterone (NET), along with estradiol (E2) and progesterone (P4), in human serum for a Shimadzu Nexera-LCMS-8050 LC-MS/MS platform. We analyzed serum collected from women self-reporting use of oral contraceptives, contraceptive implants or injectable contraceptives (n=14) and normally cycling women using no HC (n=15) as well as pooled samples from women administered various HCs (ENG, n=6; LNG, n=14; MPA, n=7; NET, n=5).

resultsLimits of quantitation were 0.010ng/mL for E2, EE2 and P4; 0.020ng/mL for ENG, LNG and MPA; and 0.040ng/mL for NET. Precisions for all assays, as indicated by coefficient of variation, were less than or equal to 12.1%. Accuracies for all assays were in the range of 95%-108%. Endogenous hormone values obtained from analysis of human serum samples are in agreement with levels previously reported in the literature for normally cycling women as well as for women taking the appropriate HC.

conclusionsWe have developed a robust, accurate and sensitive method for simultaneously analyzing commonly used contraceptive steroids and endogenous sex steroids in human serum. IMPLICATIONS: This analytical method can be used for quantitating contraceptive steroid levels in women for monitoring systemic exposure to determine drug interactions, nonadherence, misreporting and proper dosing.

Indexed as

AdultChromatography, LiquidContraceptives, OralContraceptives, Oral, CombinedEstradiolFemaleHumansProgesteroneSteroidsTandem Mass SpectrometryContraceptives, OralContraceptives, Oral, CombinedEstradiolProgesteroneSteroidsHormonal contraceptiveLC–MS/MSLiquid chromatographyMass spectrometrySteroid

Identifiers

PMID29407362
PMCPMC5840044
OpenAlexW2792298605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.